Author

D. S. Wijesinghe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:differential expression· 2 Assay:metabolomics· 2 Approach:statistical model· 2 Approach:experimental assay· 1

Frequent Co-Authors

D. Contaifer· 3 shared N. G. Kumar· 2 shared A. A. Toor· 1 shared A. P. Rossi· 1 shared B. Broering· 1 shared B. J. Fisher· 1 shared C. Chou· 1 shared C. H. Roberts· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

D. Contaifer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Pre-transplant Blood-based Lipid Signature for Prediction of Antibody-mediated Rejection in Kidney Transplant Patients

M. A. Alsultan, G. Gupta, S. Bobba, D. Contaifer, D. S. Wijesinghe

This study identifies a lipid-based biomarker panel that predicts antibody-mediated rejection in kidney transplant patients with high accuracy.

bioRxiv · Jun 21, 2022 · PreprintBiochemistry

Detecting Direct Oral Anticoagulants in Trauma Patients using Liquid Chromatography-Mass Spectrometry: a Novel Approach to Medication Reconciliation

S. Jayaraman, J. H. DeAntonio, S. W. Leichtle, J. Han, L. Liebrecht, D. Contaifer, C. Young, C. Chou, J. Staschen, D. Doan, N. G. Kumar, L. Wolfe, T. Nguyen, G. Chenault, R. J. Anand, , D. S. Wijesinghe

This paper develops an LCMS-based assay to detect DOACs in trauma patients, achieving high accuracy and identifying potential medication reconciliation issues.

bioRxiv · May 27, 2019Pharmacology & Toxicology

Risk stratification of allogeneic stem cell recipients with respect to the potential for development of GVHD via their pre-transplant plasma lipid and metabolic signature

D. Contaifer, C. H. Roberts, N. G. Kumar, R. Natarajan, B. J. Fisher, K. Leslie, J. Reed, A. A. Toor, D. S. Wijesinghe

This study identifies pre-transplant plasma lipid and metabolic biomarkers that predict graft vs. host disease (GVHD) risk in allogeneic stem cell transplant recipients with high accuracy.

bioRxiv · Nov 20, 2018Biochemistry